Enzyme replacement therapy Strensiq to benefit patients with hypophosphatasia developed in childhood
26 June, 2015
New research led by scientists at The Scripps Research Institute (TSRI), International AIDS Vaccine Initiative (IAVI) and The Rockefeller University shows in mice that an experimental vaccine candidate designed at TSRI can stimulate the immune system activity necessary to stop HIV infection. The findings could provide key information for the development of an effective AIDS vaccine.
21 June, 2015
Scientists at the University of Bath have identified that a combination of two existing licensed drugs could be used as a potential new treatment for depression.
19 June, 2015
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a new therapeutic approach that, while still preliminary, could promote the development of new bone-forming cells in patients suffering from bone loss.
15 June, 2015